Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03792724
Title Phase I-II Study of Intratumoral Urelumab Combined With Nivolumab in Patients With Solid Tumors (INTRUST)
Acronym INTRUST
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Clinica Universidad de Navarra, Universidad de Navarra
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.